Advisor Group Holdings, Inc. Akouos, Inc. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.6 - $5.16 $2 - $5	-1 Reduced 0.07%	1,358 $9,000
Q2 2022 Aug 10, 2022	BUY	$2.46 - $5.2 $3,200 - $6,765	1,301 Added 2243.1%	1,359 $6,000
Q1 2022 May 04, 2022	SELL	$4.16 - $9.08 $540 - $1,180	-130 Reduced 69.15%	58 $0
Q3 2021 Nov 05, 2021	SELL	$9.93 - $13.59 $7,070 - $9,676	-712 Reduced 79.11%	188 $2,000
Q2 2021 Aug 02, 2021	SELL	$11.87 - $15.96 $32,879 - $44,209	-2,770 Reduced 75.48%	900 $11,000
Q1 2021 May 13, 2021	BUY	$13.87 - $21.04 $50,902 - $77,216	3,670 New	3,670 $51,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.